Posted inMedical Technology
Tela Bio sues BD over hernia mesh monopoly claims
BD has become the subject of a lawsuit from Tela Bio, with the rival maker of surgical mesh implants saying…
Posted inMedical Technology
Edwards nets FDA approval for Sapien M3 transcatheter mitral valve replacement
Edwards Lifesciences has claimed an FDA approval for its Sapien M3 transcatheter mitral valve replacement system—marking the agency’s first in…
Posted inMedical Technology
Abbott’s Volt pulsed field ablation system scores FDA approval
After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field…
Posted inMedical Technology
Editor’s corner: Fierce Medtech’s top 10 stories of 2025 show how tech can treat
One of the main threads running through our most-read stories of 2025—as much as ever in the medtech industry writ…
Posted inMedical Technology
Hologic breast cancer study bolsters use of mammogram AI
Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography.…
Posted inMedical Technology
Looking ahead with BD’s Bilal Muhsin on what good AI can still do for healthcare
With all the buzzwords surrounding artificial intelligence, from smiling promotions to angry chagrins—promises that it will revolutionize how we work…
Posted inMedical Technology
Following Medtronic, J&J nets liquid embolic nod in subdural hematoma
Earlier this month, Medtronic received a new approval from the FDA for its decades-old liquid embolic system, extending its use…
Posted inMedical Technology
GlucoModicum touts needle-free Sofio glucose monitoring patch
Following years in development, the Finnish medtech GlucoModicum has unveiled its needle-free glucose monitoring patch, designed as a temporary reader…
Posted inMedical Technology
Moon Surgical enters new phase, updating robots with AI connectivity
Moon Surgical has entered a new phase. The company rolled out Wi-Fi and 5G connectivity across its installed base of…
Posted inMedical Technology
AI drug designer Insilico Medicine aims to generate nearly $300M in Hong Kong IPO
After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine has laid out plans to…